Making marks at AACR
Reading biomarker signals at AACR 2017
Biomarkers that could stratify patients, point to treatment combinations or predict toxicity were a major part of the conversation at this year’s AACR conference, where they emerged as potential difference makers for a range of high-profile technologies in immuno-oncology and other anticancer approaches.
This year’s conference of the American Association for Cancer Research saw the biomarker field grow beyond its niche as a tool for precision medicine and diagnostics, and adopt a status as an enabler of a broad range of leading-edge therapies. ...